Regeneron Pharmaceuticals (NASDAQ:REGN) outlined its C5 complement development strategy in an investor roundtable focused on cemdisiran, an siRNA targeting C5, and pozelimab, a C5-targeting antibody ...

Palestinians have voted in local elections, the first in two decades in Gaza and the first in the Israeli occupied West Bank ...

Donald Trump is attending the White House Correspondents’ dinner for the first time in more than a decade, and his first time ...

She said the glasses allow her to combine audio feedback with guidance from her running partner. “I can put my music on but ...